Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 196

1.

Genetic variability and consequence of Mycobacterium tuberculosis lineage 3 in Kampala-Uganda.

Wampande EM, Naniima P, Mupere E, Kateete DP, Malone LL, Stein CM, Mayanja-Kizza H, Gagneux S, Boom WH, Joloba ML.

PLoS One. 2019 Sep 9;14(9):e0221644. doi: 10.1371/journal.pone.0221644. eCollection 2019.

2.

Distinct serum biosignatures are associated with different tuberculosis treatment outcomes.

Ronacher K, Chegou NN, Kleynhans L, Djoba Siawaya JF, du Plessis N, Loxton AG, Maasdorp E, Tromp G, Kidd M, Stanley K, Kriel M, Menezes A, Gutschmidt A, van der Spuy GD, Warren RM, Dietze R, Okwera A, Thiel B, Belisle JT, Cliff JM, Boom WH, Johnson JL, van Helden PD, Dockrell HM, Walzl G.

Tuberculosis (Edinb). 2019 Aug 12;118:101859. doi: 10.1016/j.tube.2019.101859. [Epub ahead of print]

PMID:
31434026
3.

Publisher Correction: IFN-γ-independent immune markers of Mycobacterium tuberculosis exposure.

Lu LL, Smith MT, Yu KKQ, Luedemann C, Suscovich TJ, Grace PS, Cain A, Yu WH, McKitrick TR, Lauffenburger D, Cummings RD, Mayanja-Kizza H, Hawn TR, Boom WH, Stein CM, Fortune SM, Seshadri C, Alter G.

Nat Med. 2019 Jul;25(7):1175. doi: 10.1038/s41591-019-0519-y.

PMID:
31222179
4.

Beyond compensation? Examining the role of apologies in the restoration of victims' needs in simulated tort cases.

Reinders Folmer CP, Desmet PTM, Van Boom WH.

Law Hum Behav. 2019 Aug;43(4):329-341. doi: 10.1037/lhb0000335. Epub 2019 Jun 13.

PMID:
31192628
5.

IFN-γ-independent immune markers of Mycobacterium tuberculosis exposure.

Lu LL, Smith MT, Yu KKQ, Luedemann C, Suscovich TJ, Grace PS, Cain A, Yu WH, McKitrick TR, Lauffenburger D, Cummings RD, Mayanja-Kizza H, Hawn TR, Boom WH, Stein CM, Fortune SM, Seshadri C, Alter G.

Nat Med. 2019 Jun;25(6):977-987. doi: 10.1038/s41591-019-0441-3. Epub 2019 May 20. Erratum in: Nat Med. 2019 Jun 20;:.

PMID:
31110348
6.

Recognition of CD8+ T-cell epitopes to identify adults with pulmonary tuberculosis.

Lancioni C, Swarbrick GM, Park B, Nyendak M, Nsereko M, Mayanja-Kizza H, Null MD, Cansler ME, Duncan RB, Baseke J, Chervenak K, Malone L, Heaphy EG, Boom WH, Lewinsohn DM, Lewinsohn DA.

Eur Respir J. 2019 May 30;53(5). pii: 1802053. doi: 10.1183/13993003.02053-2018. Print 2019 May. No abstract available.

PMID:
30923183
7.

Correction to "Elucidation of a Novel Human Urine Metabolite as a Seryl-Leucine Glycopeptide and as a Biomarker of Effective Anti-Tuberculosis Therapy".

Fitzgerald BL, Islam MN, Graham B, Mahapatra S, Webb K, Boom WH, Malherbe ST, Joloba ML, Johnson JL, Winter J, Walzl G, Belisle JT.

ACS Infect Dis. 2019 Jun 14;5(6):1042-1043. doi: 10.1021/acsinfecdis.9b00068. Epub 2019 Mar 13. No abstract available.

8.

Elucidation of a Human Urine Metabolite as a Seryl-Leucine Glycopeptide and as a Biomarker of Effective Anti-Tuberculosis Therapy.

Fitzgerald BL, Islam MN, Graham B, Mahapatra S, Webb K, Boom WH, Malherbe ST, Joloba ML, Johnson JL, Winter J, Walzl G, Belisle JT.

ACS Infect Dis. 2019 Mar 8;5(3):353-364. doi: 10.1021/acsinfecdis.8b00241. Epub 2019 Jan 10. Erratum in: ACS Infect Dis. 2019 Jun 14;5(6):1042-1043.

9.

Metabolite changes in blood predict the onset of tuberculosis.

Weiner J 3rd, Maertzdorf J, Sutherland JS, Duffy FJ, Thompson E, Suliman S, McEwen G, Thiel B, Parida SK, Zyla J, Hanekom WA, Mohney RP, Boom WH, Mayanja-Kizza H, Howe R, Dockrell HM, Ottenhoff THM, Scriba TJ, Zak DE, Walzl G, Kaufmann SHE; GC6-74 consortium.

Nat Commun. 2018 Dec 6;9(1):5208. doi: 10.1038/s41467-018-07635-7.

10.

Long-term Stability of Resistance to Latent Mycobacterium tuberculosis Infection in Highly Exposed Tuberculosis Household Contacts in Kampala, Uganda.

Stein CM, Nsereko M, Malone LL, Okware B, Kisingo H, Nalukwago S, Chervenak K, Mayanja-Kizza H, Hawn TR, Boom WH.

Clin Infect Dis. 2019 May 2;68(10):1705-1712. doi: 10.1093/cid/ciy751.

11.

Bacterial Factors That Predict Relapse after Tuberculosis Therapy.

Colangeli R, Jedrey H, Kim S, Connell R, Ma S, Chippada Venkata UD, Chakravorty S, Gupta A, Sizemore EE, Diem L, Sherman DR, Okwera A, Dietze R, Boom WH, Johnson JL, Mac Kenzie WR, Alland D; DMID 01-009/Tuberculosis Trials Consortium Study 22 Teams.

N Engl J Med. 2018 Aug 30;379(9):823-833. doi: 10.1056/NEJMoa1715849.

12.

Fine-mapping analysis of a chromosome 2 region linked to resistance to Mycobacterium tuberculosis infection in Uganda reveals potential regulatory variants.

Igo RP Jr, Hall NB, Malone LL, Hall JB, Truitt B, Qiu F, Tao L, Mupere E, Schnell A, Hawn TR, Bush WS, Joloba M, Boom WH, Stein CM.

Genes Immun. 2019 Jul;20(6):473-483. doi: 10.1038/s41435-018-0040-1. Epub 2018 Aug 13.

13.

Mycobacterium tuberculosis Lipoprotein and Lipoglycan Binding to Toll-Like Receptor 2 Correlates with Agonist Activity and Functional Outcomes.

Shukla S, Richardson ET, Drage MG, Boom WH, Harding CV.

Infect Immun. 2018 Sep 21;86(10). pii: e00450-18. doi: 10.1128/IAI.00450-18. Print 2018 Oct.

14.

Impact of geographic distance on appraisal delay for active TB treatment seeking in Uganda: a network analysis of the Kawempe Community Health Cohort Study.

Fluegge K, Malone LL, Nsereko M, Okware B, Wejse C, Kisingo H, Mupere E, Boom WH, Stein CM.

BMC Public Health. 2018 Jun 26;18(1):798. doi: 10.1186/s12889-018-5648-6.

15.

The effect of interrupted anti-retroviral treatment on the reconstitution of memory and naive T cells during tuberculosis treatment in HIV patients with active pulmonary tuberculosis.

Nalukwago S, Lancioni CL, Oketcho JB, Canaday DHE, Boom WH, Ojok L, Mayanja-Kizza H.

Afr Health Sci. 2017 Dec;17(4):954-962. doi: 10.4314/ahs.v17i4.2.

16.

Immunological mechanisms of human resistance to persistent Mycobacterium tuberculosis infection.

Simmons JD, Stein CM, Seshadri C, Campo M, Alter G, Fortune S, Schurr E, Wallis RS, Churchyard G, Mayanja-Kizza H, Boom WH, Hawn TR.

Nat Rev Immunol. 2018 Sep;18(9):575-589. doi: 10.1038/s41577-018-0025-3. Review.

17.

Genomics of human pulmonary tuberculosis: from genes to pathways.

Stein CM, Sausville L, Wejse C, Sobota RS, Zetola NM, Hill PC, Boom WH, Scott WK, Sirugo G, Williams SM.

Curr Genet Med Rep. 2017 Dec;5(4):149-166. doi: 10.1007/s40142-017-0130-9. Epub 2017 Oct 12.

18.

A Serum Circulating miRNA Signature for Short-Term Risk of Progression to Active Tuberculosis Among Household Contacts.

Duffy FJ, Thompson E, Downing K, Suliman S, Mayanja-Kizza H, Boom WH, Thiel B, Weiner Iii J, Kaufmann SHE, Dover D, Tabb DL, Dockrell HM, Ottenhoff THM, Tromp G, Scriba TJ, Zak DE, Walzl G; GC6-74 Consortium.

Front Immunol. 2018 Apr 13;9:661. doi: 10.3389/fimmu.2018.00661. eCollection 2018.

19.

Four-gene Pan-African Blood Signature Predicts Progression to Tuberculosis.

Suliman S, Thompson E, Sutherland J, Weiner Rd J, Ota MOC, Shankar S, Penn-Nicholson A, Thiel B, Erasmus M, Maertzdorf J, Duffy FJ, Hill PC, Hughes EJ, Stanley K, Downing K, Fisher ML, Valvo J, Parida SK, van der Spuy G, Tromp G, Adetifa IMO, Donkor S, Howe R, Mayanja-Kizza H, Boom WH, Dockrell H, Ottenhoff THM, Hatherill M, Aderem A, Hanekom WA, Scriba TJ, Kaufmann SH, Zak DE, Walzl G; GC6-74 and ACS cohort study groups.

Am J Respir Crit Care Med. 2018 Apr 6. doi: 10.1164/rccm.201711-2340OC. [Epub ahead of print]

20.

Resistance and Susceptibility to Mycobacterium tuberculosis Infection and Disease in Tuberculosis Households in Kampala, Uganda.

Stein CM, Zalwango S, Malone LL, Thiel B, Mupere E, Nsereko M, Okware B, Kisingo H, Lancioni CL, Bark CM, Whalen CC, Joloba ML, Boom WH, Mayanja-Kizza H.

Am J Epidemiol. 2018 Jul 1;187(7):1477-1489. doi: 10.1093/aje/kwx380.

21.

Effectiveness of WHO's pragmatic screening algorithm for child contacts of tuberculosis cases in resource-constrained settings: a prospective cohort study in Uganda.

Martinez L, Shen Y, Handel A, Chakraburty S, Stein CM, Malone LL, Boom WH, Quinn FD, Joloba ML, Whalen CC, Zalwango S.

Lancet Respir Med. 2018 Apr;6(4):276-286. doi: 10.1016/S2213-2600(17)30497-6. Epub 2017 Dec 19.

22.

Erratum for Alsultan et al., "Population Pharmacokinetics of AZD-5847 in Adults with Pulmonary Tuberculosis".

Alsultan A, Furin JJ, Du Bois J, van Brakel E, Chheng P, Venter A, Thiel B, Debanne SA, Boom WH, Diacon AH, Johnson JL, Peloquin CA.

Antimicrob Agents Chemother. 2017 Dec 21;62(1). pii: e02229-17. doi: 10.1128/AAC.02229-17. Print 2018 Jan. No abstract available.

23.

Sequential inflammatory processes define human progression from M. tuberculosis infection to tuberculosis disease.

Scriba TJ, Penn-Nicholson A, Shankar S, Hraha T, Thompson EG, Sterling D, Nemes E, Darboe F, Suliman S, Amon LM, Mahomed H, Erasmus M, Whatney W, Johnson JL, Boom WH, Hatherill M, Valvo J, De Groote MA, Ochsner UA, Aderem A, Hanekom WA, Zak DE; other members of the ACS cohort study team.

PLoS Pathog. 2017 Nov 16;13(11):e1006687. doi: 10.1371/journal.ppat.1006687. eCollection 2017 Nov.

24.

Proteomics and Network Analyses Reveal Inhibition of Akt-mTOR Signaling in CD4+ T Cells by Mycobacterium tuberculosis Mannose-Capped Lipoarabinomannan.

Karim AF, Sande OJ, Tomechko SE, Ding X, Li M, Maxwell S, Ewing RM, Harding CV, Rojas RE, Chance MR, Boom WH.

Proteomics. 2017 Nov;17(22). doi: 10.1002/pmic.201700233.

25.

Comprehensive definition of human immunodominant CD8 antigens in tuberculosis.

Lewinsohn DA, Swarbrick GM, Park B, Cansler ME, Null MD, Toren KG, Baseke J, Zalwango S, Mayanja-Kizza H, Malone LL, Nyendak M, Wu G, Guinn K, McWeeney S, Mori T, Chervenak KA, Sherman DR, Boom WH, Lewinsohn DM.

NPJ Vaccines. 2017;2. pii: 8. doi: 10.1038/s41541-017-0008-6. Epub 2017 Apr 3.

26.

Population Pharmacokinetics of AZD-5847 in Adults with Pulmonary Tuberculosis.

Alsultan A, Furin JJ, Du Bois J, van Brakel E, Chheng P, Venter A, Thiel B, Debanne SA, Boom WH, Diacon AH, Johnson JL, Peloquin CA.

Antimicrob Agents Chemother. 2017 Sep 22;61(10). pii: e01066-17. doi: 10.1128/AAC.01066-17. Print 2017 Oct. Erratum in: Antimicrob Agents Chemother. 2017 Dec 21;62(1):.

27.

Toll like Receptor 2 engagement on CD4+ T cells promotes TH9 differentiation and function.

Karim AF, Reba SM, Li Q, Boom WH, Rojas RE.

Eur J Immunol. 2017 Sep;47(9):1513-1524. doi: 10.1002/eji.201646846. Epub 2017 Jul 18.

28.

Identification of Host Proteins Predictive of Early Stage Mycobacterium tuberculosis Infection.

Bark CM, Manceur AM, Malone LL, Nsereko M, Okware B, Mayanja HK, Joloba ML, Rajotte I, Mentinova M, Kay P, Lo S, Tremblay P, Stein CM, Boom WH, Paramithiotis E.

EBioMedicine. 2017 Jul;21:150-157. doi: 10.1016/j.ebiom.2017.06.019. Epub 2017 Jun 20.

29.

A chromosome 5q31.1 locus associates with tuberculin skin test reactivity in HIV-positive individuals from tuberculosis hyper-endemic regions in east Africa.

Sobota RS, Stein CM, Kodaman N, Maro I, Wieland-Alter W, Igo RP Jr, Magohe A, Malone LL, Chervenak K, Hall NB, Matee M, Mayanja-Kizza H, Joloba M, Moore JH, Scott WK, Lahey T, Boom WH, von Reyn CF, Williams SM, Sirugo G.

PLoS Genet. 2017 Jun 19;13(6):e1006710. doi: 10.1371/journal.pgen.1006710. eCollection 2017 Jun.

30.

Transcriptional networks are associated with resistance to Mycobacterium tuberculosis infection.

Seshadri C, Sedaghat N, Campo M, Peterson G, Wells RD, Olson GS, Sherman DR, Stein CM, Mayanja-Kizza H, Shojaie A, Boom WH, Hawn TR; Tuberculosis Research Unit (TBRU).

PLoS One. 2017 Apr 17;12(4):e0175844. doi: 10.1371/journal.pone.0175844. eCollection 2017.

31.

Mycobacterium tuberculosis Membrane Vesicles Inhibit T Cell Activation.

Athman JJ, Sande OJ, Groft SG, Reba SM, Nagy N, Wearsch PA, Richardson ET, Rojas R, Boom WH, Shukla S, Harding CV.

J Immunol. 2017 Mar 1;198(5):2028-2037. doi: 10.4049/jimmunol.1601199. Epub 2017 Jan 25.

32.

Human leukocyte antigen class 1 genotype distribution and analysis in persons with active tuberculosis and household contacts from Central Uganda.

Buteme HK, Axelsson-Robertson R, Benson L, Joloba ML, Boom WH, Kallenius G, Maeurer M.

BMC Infect Dis. 2016 Sep 23;16(1):504.

33.

Early Bactericidal Activity of AZD5847 in Patients with Pulmonary Tuberculosis.

Furin JJ, Du Bois J, van Brakel E, Chheng P, Venter A, Peloquin CA, Alsultan A, Thiel BA, Debanne SM, Boom WH, Diacon AH, Johnson JL.

Antimicrob Agents Chemother. 2016 Oct 21;60(11):6591-6599. doi: 10.1128/AAC.01163-16. Print 2016 Nov.

34.

Bacillus Calmette-Guérin (BCG) Revaccination of Adults with Latent Mycobacterium tuberculosis Infection Induces Long-Lived BCG-Reactive NK Cell Responses.

Suliman S, Geldenhuys H, Johnson JL, Hughes JE, Smit E, Murphy M, Toefy A, Lerumo L, Hopley C, Pienaar B, Chheng P, Nemes E, Hoft DF, Hanekom WA, Boom WH, Hatherill M, Scriba TJ.

J Immunol. 2016 Aug 15;197(4):1100-1110. doi: 10.4049/jimmunol.1501996. Epub 2016 Jul 13.

35.

Activity of nitazoxanide and tizoxanide against Mycobacterium tuberculosis in vitro and in whole blood culture.

Harausz EP, Chervenak KA, Good CE, Jacobs MR, Wallis RS, Sanchez-Felix M, Boom WH; TB Research Unit (TBRU) at Case Western Reserve University.

Tuberculosis (Edinb). 2016 May;98:92-6. doi: 10.1016/j.tube.2016.03.002. Epub 2016 Mar 22.

36.

A blood RNA signature for tuberculosis disease risk: a prospective cohort study.

Zak DE, Penn-Nicholson A, Scriba TJ, Thompson E, Suliman S, Amon LM, Mahomed H, Erasmus M, Whatney W, Hussey GD, Abrahams D, Kafaar F, Hawkridge T, Verver S, Hughes EJ, Ota M, Sutherland J, Howe R, Dockrell HM, Boom WH, Thiel B, Ottenhoff THM, Mayanja-Kizza H, Crampin AC, Downing K, Hatherill M, Valvo J, Shankar S, Parida SK, Kaufmann SHE, Walzl G, Aderem A, Hanekom WA; ACS and GC6-74 cohort study groups.

Lancet. 2016 Jun 4;387(10035):2312-2322. doi: 10.1016/S0140-6736(15)01316-1. Epub 2016 Mar 24.

37.

A Locus at 5q33.3 Confers Resistance to Tuberculosis in Highly Susceptible Individuals.

Sobota RS, Stein CM, Kodaman N, Scheinfeldt LB, Maro I, Wieland-Alter W, Igo RP Jr, Magohe A, Malone LL, Chervenak K, Hall NB, Modongo C, Zetola N, Matee M, Joloba M, Froment A, Nyambo TB, Moore JH, Scott WK, Lahey T, Boom WH, von Reyn CF, Tishkoff SA, Sirugo G, Williams SM.

Am J Hum Genet. 2016 Mar 3;98(3):514-524. doi: 10.1016/j.ajhg.2016.01.015.

38.

Mannose-Capped Lipoarabinomannan from Mycobacterium tuberculosis Induces CD4+ T Cell Anergy via GRAIL.

Sande OJ, Karim AF, Li Q, Ding X, Harding CV, Rojas RE, Boom WH.

J Immunol. 2016 Jan 15;196(2):691-702. doi: 10.4049/jimmunol.1500710. Epub 2015 Dec 14.

39.

Tuberculosis case finding in first-degree relative contacts not living with index tuberculosis cases in Kampala, Uganda.

Chheng P, Nsereko M, Malone LL, Okware B, Zalwango S, Joloba M, Boom WH, Mupere E, Stein CM.

Clin Epidemiol. 2015 Oct 13;7:411-9. doi: 10.2147/CLEP.S82389. eCollection 2015.

40.

ERK Signaling Is Essential for Macrophage Development.

Richardson ET, Shukla S, Nagy N, Boom WH, Beck RC, Zhou L, Landreth GE, Harding CV.

PLoS One. 2015 Oct 7;10(10):e0140064. doi: 10.1371/journal.pone.0140064. eCollection 2015.

41.

Distribution and transmission of Mycobacterium tuberculosis complex lineages among children in peri-urban Kampala, Uganda.

Wampande EM, Mupere E, Jaganath D, Nsereko M, Mayanja HK, Eisenach K, Boom WH, Gagneux S, Joloba ML; Tuberculosis Research Unit.

BMC Pediatr. 2015 Sep 30;15:140. doi: 10.1186/s12887-015-0455-z.

42.

A single-nucleotide-polymorphism real-time PCR assay for genotyping of Mycobacterium tuberculosis complex in peri-urban Kampala.

Wampande EM, Hatzios SK, Achan B, Mupere E, Nsereko M, Mayanja HK, Eisenach K, Boom WH, Gagneux S, Joloba ML; Tuberculosis Research Unit.

BMC Infect Dis. 2015 Sep 30;15:396. doi: 10.1186/s12879-015-1121-7.

43.

Proteomic and bioinformatics profile of paired human alveolar macrophages and peripheral blood monocytes.

Tomechko SE, Lundberg KC, Jarvela J, Bebek G, Chesnokov NG, Schlatzer D, Ewing RM, Boom WH, Chance MR, Silver RF.

Proteomics. 2015 Nov;15(22):3797-805. doi: 10.1002/pmic.201400496.

44.

A side-by-side comparison of T cell reactivity to fifty-nine Mycobacterium tuberculosis antigens in diverse populations from five continents.

Carpenter C, Sidney J, Kolla R, Nayak K, Tomiyama H, Tomiyama C, Padilla OA, Rozot V, Ahamed SF, Ponte C, Rolla V, Antas PR, Chandele A, Kenneth J, Laxmi S, Makgotlho E, Vanini V, Ippolito G, Kazanova AS, Panteleev AV, Hanekom W, Mayanja-Kizza H, Lewinsohn D, Saito M, McElrath MJ, Boom WH, Goletti D, Gilman R, Lyadova IV, Scriba TJ, Kallas EG, Murali-Krishna K, Sette A, Lindestam Arlehamn CS.

Tuberculosis (Edinb). 2015 Dec;95(6):713-721. doi: 10.1016/j.tube.2015.07.001. Epub 2015 Aug 1.

45.

Incubation time of Mycobacterium tuberculosis complex sputum cultures in BACTEC MGIT 960: 4weeks of negative culture is enough for physicians to consider alternative diagnoses.

Ogwang S, Mubiri P, Bark CM, Joloba ML, Boom WH, Johnson JL.

Diagn Microbiol Infect Dis. 2015 Oct;83(2):162-4. doi: 10.1016/j.diagmicrobio.2015.07.002. Epub 2015 Jul 9.

46.

Sulfamethoxazole susceptibility of Mycobacterium tuberculosis isolates from HIV-infected Ugandan adults with tuberculosis taking trimethoprim-sulfamethoxazole prophylaxis.

Ogwang S, Good CE, Okware B, Nsereko M, Jacobs MR, Boom WH, Bark CM.

Antimicrob Agents Chemother. 2015 Sep;59(9):5844-6. doi: 10.1128/AAC.01101-15. Epub 2015 Jul 13.

47.

Bacterial Membrane Vesicles Mediate the Release of Mycobacterium tuberculosis Lipoglycans and Lipoproteins from Infected Macrophages.

Athman JJ, Wang Y, McDonald DJ, Boom WH, Harding CV, Wearsch PA.

J Immunol. 2015 Aug 1;195(3):1044-53. doi: 10.4049/jimmunol.1402894. Epub 2015 Jun 24.

48.

Toll-like receptor 2-dependent extracellular signal-regulated kinase signaling in Mycobacterium tuberculosis-infected macrophages drives anti-inflammatory responses and inhibits Th1 polarization of responding T cells.

Richardson ET, Shukla S, Sweet DR, Wearsch PA, Tsichlis PN, Boom WH, Harding CV.

Infect Immun. 2015 Jun;83(6):2242-54. doi: 10.1128/IAI.00135-15. Epub 2015 Mar 16.

49.

Comparison of MGIT and Myco/F lytic liquid-based blood culture systems for recovery of Mycobacterium tuberculosis from pleural fluid.

Harausz E, Lusiba JK, Nsereko M, Johnson JL, Toossi Z, Ogwang S, Boom WH, Joloba ML; Tuberculosis Research Unit (TBRU).

J Clin Microbiol. 2015 Apr;53(4):1391-4. doi: 10.1128/JCM.02742-14. Epub 2015 Feb 4.

50.

Polymorphisms in TICAM2 and IL1B are associated with TB.

Hall NB, Igo RP Jr, Malone LL, Truitt B, Schnell A, Tao L, Okware B, Nsereko M, Chervenak K, Lancioni C, Hawn TR, Mayanja-Kizza H, Joloba ML, Boom WH, Stein CM; Tuberculosis Research Unit (TBRU).

Genes Immun. 2015 Mar;16(2):127-133. doi: 10.1038/gene.2014.77. Epub 2014 Dec 18.

Supplemental Content

Support Center